RxDoctor Payments Data

Andrew Cohen, MD

Urology · Baltimore, MDNPI 1144575689

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (44.0%), food and beverage and grants — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Intuitive Surgical at 58.9% of the total.

$12,512in general payments, 2019–2025

Across 63 payments — averaging $198.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • Boston Scientific$3K
  • Endo USA, Inc.$601
  • Verathon Inc.$500
  • Procept Biorobotics Corporation$188
  • 180 Medical, Inc.$108
  • plus $443 from 12 others

What the payments were for

  • Consulting fees$1,0008%
  • Grants$2,00016%
  • Travel & lodging$1,77114%
  • Food & beverage$2,24118%
  • Education$5,50044%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,512 in reported general payments places this provider in the 80th percentile of 274 urology providers in Maryland.

See all urology providers in Maryland →

Medicare billing

Part B allowed, 2024
$168,188
Medicare patients
482
Services billed
1,016

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron47$31,815
Tamsulosin Hcl194$4,575
Trospium Chloride ErTrospium Chloride20$2,507
Trospium Chloride20$2,117
Finasteride122$2,010
Tolterodine Tartrate ErTolterodine Tartrate28$1,669
Methenamine Hippurate20$1,215
Silodosin26$957
Dutasteride15$769
Alfuzosin Hcl ErAlfuzosin Hcl28$654
Oxybutynin Chloride ErOxybutynin Chloride20$515
Oxycodone Hcl14$31

Paid to pharmacies, not to this prescriber.

Other urology in Baltimore

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →